Hospira’s original biosimilar portfolio has been merged with other divisions within Pfizer, and the global infusion therapy ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

A full pharmacokinetic profile of SBS-1000 IV infusion was also characterized ... SBS-1000 has been supported by a National Institutes of Health/ National Institute of Drug Abuse UG3/UH3 grant. About ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Having been in long-term relationships since age 16, I have experienced my fair share of heartbreak. But this last one hit ...

INDIGO is the largest clinical trial conducted in patients living with IgG4-RD--Topline INDIGO results expected by the end of 2025-WALTHAM, ...

Sarepta has stopped developing SRP-5051, its exon 51-skipping therapy for Duchenne MD, due to long-term safety concerns and ...

(WRIC) — An intravenous (IV) fluid shortage in the wake of Hurricane ... The company has also received approval from the Food ...

U.S. hospitals are experiencing a shortage of IV fluids, triggered by a disruption at Baxter's North Carolina plant following Hurricane Helene. As hospitals have scrambled to conserve supplies, at ...

Overall, clinicians utilize guidance for inserting peripheral IV catheters, and studies show clinical and financial benefits ...

Read about how an agency nurse made errors while administering medication in a nursing home and also failed to adequately ...

RICHMOND, Calif., November 12, 2024 -- ( BUSINESS WIRE )--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial ...